Rocket Pharmaceuticals Inc (RCKT) returns
Rocket Pharmaceuticals returns over 10 years
$1,000 invested in Rocket Pharmaceuticals ten years ago was worth $85.32 at the close on October 30, 2026, with dividends reinvested: an average return of -21.8% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -7.2% | — | $927.76 | -0.9% |
| 3 months | -24.0% | — | $760.12 | +2.1% |
| Year to date | -30.5% | — | $695.16 | +11.7% |
| 1 year | -34.1% | — | $659.46 | +12.4% |
| 3 years | -86.7% | -49.0% | $132.54 | +88.5% |
| 5 years | -91.8% | -39.3% | $82.13 | +76.0% |
| 10 years | -91.5% | -21.8% | $85.32 | +316.6% |
Rocket Pharmaceuticals return by calendar year
| Year | RCKT | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -30.5% | +11.7% | -42.2% |
| 2025 | -72.1% | +17.7% | -89.8% |
| 2024 | -58.1% | +24.9% | -82.9% |
| 2023 | +53.1% | +26.2% | +27.0% |
| 2022 | -10.4% | -18.2% | +7.8% |
| 2021 | -60.2% | +28.7% | -88.9% |
| 2020 | +140.9% | +18.4% | +122.6% |
| 2019 | +53.6% | +31.2% | +22.4% |
| 2018 | +42.0% | -4.6% | +46.5% |
| 2017 | -57.2% | +21.7% | -78.9% |
| 2016 | -46.2% | +12.0% | -58.2% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Rocket Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.